Matches in Nanopublications for { ?s ?p "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP747976.RAUZBR4ekMgqml3ZzIAxYnThXxSdIUQ7glo4WqjOi5dd8130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747976.RAUZBR4ekMgqml3ZzIAxYnThXxSdIUQ7glo4WqjOi5dd8130_provenance.
- NP802021.RA8Ldyda8pqN76zIIFV6RZaTnzQr34oqIRaLZmigN4e9Q130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802021.RA8Ldyda8pqN76zIIFV6RZaTnzQr34oqIRaLZmigN4e9Q130_provenance.
- NP898520.RAFjNNxZmJMmPu2z4OIeevAoJPPmRRA7bLN_uYf1AAmQ8130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898520.RAFjNNxZmJMmPu2z4OIeevAoJPPmRRA7bLN_uYf1AAmQ8130_provenance.
- NP817718.RAVe4Q9Siyu2jzz3j1IVPV0U3wPTJo6y4L5OBGMR1xD84130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817718.RAVe4Q9Siyu2jzz3j1IVPV0U3wPTJo6y4L5OBGMR1xD84130_provenance.
- NP966386.RAxj1HB6u7V32-yyHmqerlNbBuwd1tf1py3EwH5m-XYbI130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966386.RAxj1HB6u7V32-yyHmqerlNbBuwd1tf1py3EwH5m-XYbI130_provenance.
- NP231760.RAHmzckRbrc5Qoynt7U3_JOJQppgk691UBTmI3rBrGHJY130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231760.RAHmzckRbrc5Qoynt7U3_JOJQppgk691UBTmI3rBrGHJY130_provenance.
- NP966389.RAdTBR0H68o5t8ZVX9CBhfIX6bHN86XPIh3id9HLLI41Q130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966389.RAdTBR0H68o5t8ZVX9CBhfIX6bHN86XPIh3id9HLLI41Q130_provenance.
- NP966388.RAkwbuLABlR6f6jYYGB83VrsWNG4b7sX8lSpW55QGqaoE130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966388.RAkwbuLABlR6f6jYYGB83VrsWNG4b7sX8lSpW55QGqaoE130_provenance.
- NP902407.RANIGtDt5UlHEH8v6nxSfxHsz4apLOmcBZFg-Wx06bW-0130_assertion description "[AIM1 promoter hypermethylation was found in higher frequency (P = 0.005) in metastatic melanoma (65%) than in primary melanomas (38%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902407.RANIGtDt5UlHEH8v6nxSfxHsz4apLOmcBZFg-Wx06bW-0130_provenance.